Traditional Chinese medicine prevents inflammation in CCl 4-related liver injury in mice

American Journal of Chinese Medicine

Volumn 31, Issue 1, 2003, Pages 119-127

  Li, Y M ^a   Ryan, P ^a   Batey, Robert ^b  

^a Cathay Herbal Laboratories   (Australia)

^b JOHN HUNTER HOSPITAL   (Australia)

Author keywords

Carbon Tetrachloride; CH100; Chinese Herbal Medicine; Hepatitis C; Treatment of Liver Disease

Indexed keywords

ALANINE AMINOTRANSFERASE; CARBON TETRACHLORIDE; CH 100; CH 101; HERBACEOUS AGENT; LIVER ENZYME; LIVER PROTECTIVE AGENT; SILYMARIN; SODIUM CHLORIDE; CH100 HERBAL PREPARATION; CH101 HERBAL PREPARATION; PROTECTIVE AGENT;

ALTERNATIVE MEDICINE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHINESE HERB; CHINESE MEDICINE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFICACY; HEPATITIS; LIVER CELL DAMAGE; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER INJURY; LIVER PROTECTION; MOUSE; NONHUMAN; ANIMAL; BLOOD; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; FEMALE; INTOXICATION; LIVER; MALE; PATHOLOGY; PREGNANCY; TOXIC HEPATITIS;

ALANINE TRANSAMINASE; ANIMALS; CARBON TETRACHLORIDE POISONING; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; FEMALE; HEPATITIS, TOXIC; LIVER; MALE; MICE; PREGNANCY; PROTECTIVE AGENTS; SILYMARIN;

EID: 0041381051     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X03000680     Document Type: Article

References (20)

1. Batey, R.G., A. Bensoussan, S. Bollipo and M.A. Hussein. Preliminary report of a randomised, double-blind, placebo-controlled trial of a Chinese herbal medicine preparation CH-100 in the treatment of chronic hepatitis C. J. Gastro. Hepatol. 13: 244-247, 1998.
2. Batey, R.G., Q. Cao and R. Clancy. Effects of CH-100, a Chinese herbal medicine on the pathogenesis of acute concanavalin A mediated hepatitis in alcohol fed rats. Clin. Exp. Res. 24: 852-858, 2000.
3. Boigk, G., L. Stroeder, J. Waldschmidt, E.D. Riecken and D. Schuppan. Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats. Hepatology 26: 643-649, 1997.
4. Cohen, M.R. Herbal and complementary and alternative therapies for liver disease. Clin. Liver Dis. 5: 461-478, 2001.
5. Fau, D., M. Likehal, G. Farrell, A. Moreau, G. Moulis, G. Feldmann and D. Haouzi. Diterpenoids from germander, an herbal medicine, induce apoptosis in isolated rat hepatocytes. Gastroenterology 113: 1334-1346, 1997.
6. Flora, K., M. Hahn, H. Rosen and K. Benner. Milk Thistle (Silybum marinarum) for the therapy of liver disease. Am. J. Gastroenierol. 93: 139-143, 1998.
7. Garcia-Tsao, G. Portal hypertension. Curr. Opin. Gastroenterol. 14: 256-264, 1998.
8. Garcia-Villareal, L., J.M. Zozaya, M. Betes, J.I. Herrero and J. Prieto. Transjugular intrahepatic portal systemic shunt in the treatment of refractory ascites: effect on cerebral, renal, humoral and hemodynamic parameters. Hepatology 21: 986-994, 1995.
9. Lieber, C.S. Alcoholic liver disease: new insights in pathogenesis lead to new treatments. J. Hepatol. 32(Suppl): 113-128, 2000.
10. Lieber, C.S. Ethanol metabolism, cirrhosis and alcoholism. Clinica Chim Acta 257: 59-84, 1997.
11. Liu, J., Y. Liu and Q. Mao. The effects of 110 triterpenoid compounds on experimental liver injury in mice. Fundam Appl. Toxicol. 22: 34-40, 1994.
12. Maclennan, A.H., D.H. Wilson and A.W. Taylor. Prevalence and cost of alternative medicine use in Australia. Lancet 347: 569-573, 1996.
13. Mollison, L., L. Totten, C. Hovell, K. Thayne, C. Connelly and L. Booth. A randomized, double-blind, placebo controlled trial of a Chinese Herbal Medicine (CH100) in chronic hepatitis C. Gastroenterology 120(Suppl): A3 84, 2001.
14. Prevalence of use of complementary/alternative medicine: a systematic review. Bull. World Health Org. 78: 252-257, 2000.
15. Shebab, T.M. and R.H. Moseley. Viral hepatitis. Curr. Opin. Gastroenterol. 14: 228-233, 1998.
16. Shimzu, I., Y.R. Ma, Y. Mizobuchi, F. Lui, T. Miura, Y. Nakai, M. Yasuda, M. Shiba, T. Hone, S. Amagaya, N. Kawada, H, Hori and S. Ito. Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats. Hepatology 29: 149-160, 1999.
17. Simanek, V., J. Kren, J. Ultrichova, J. Vicar and L. Cvak. Silymarin. What is in the name...? An appeal for a change of editorial policy. Hepatology 32: 442-444, 2000.
18. Sladden, T.J., R.G. Batey and N. Keefe. A trial of a Chinese herbal medicine for chronic hepatitis C. Gastroenterology 120(Suppl): A382, 2001.
19. Veeramah, E.K. and S. Holmes. Complementary therapy: complement or threat to modern medicine? J. R. Soc. Health 120: 42-46, 2000.
20. Yu, A.S. and K.-Q. Hu. Management of ascites. Clin. Liver Dis. 5: 541-568, 2001.